-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

Benzinga·11/03/2026 13:48:23
Listen to the news
Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.